Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium

Critical Care Medicine

Volumn 30, Issue 1, 2002, Pages 218-225

  Hoffmann, Johannes N ^a   Vollmar, Brigitte ^b   Römisch, Jürgen ^c   Inthorn, Dietrich ^a   Schildberg, Friedrich W ^a   Menger, Michael D ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Antithrombin; Coagulation; Endothelium; Endotoxin; Mechanisms; Microcirculation; Pathophysiology; Proteinase; Sepsis; Thrombin

Indexed keywords

ANTITHROMBIN III CONCENTRATE; ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE; GLYCOSAMINOGLYCAN; KYBERNIN P; LIPOPOLYSACCHARIDE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; ENDOTOXEMIA; LEUKOCYTE ADHERENCE; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; SKINFOLD; SYRIAN HAMSTER; VASCULAR ENDOTHELIUM;

EID: 0036155210     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201000-00031     Document Type: Article

References (39)

1. Modulators of coagulation. A critical appraisal of their role in sepsis
2. AT III in septicemia with DIC
3. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies
4. Antithrombin: Its physiological importance and role in DIC
5. Coagulation inhibitor substitution during sepsis
6. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia
7. Antithrombin III in animal models of sepsis and organ failure
8. Combined antithrombin and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin
9. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
10. Antithrombin III supplementation in severe sepsis: Beneficial effects on organ dysfunction
11. Therapeutic use of antithrombin concentrate in sepsis
12. Effect of antithrombin III supplementation on inflammatory immune response in patients with severe sepsis
13. Effect of long-term antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis
14. Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin
15. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III
16. The hamster cheek pouch preparation as a model for studies of macromolecular permeability of the microvasculature
17. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells
18. Antithrombin replacement in DIC and MOF
19. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin
20. Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats
21. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway
22. Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin: An intravital microscopic study in the skin fold chamber of the hamster
23. The heparin binding site of antithrombin III. Identification of a critical tryptophan in the aminoacid sequence
24. Scope and perspectives of intravital microscopy-bridge over from in vitro to in vivo
25. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "no reflow."
26. Technical report - A new chamber technique for microvascular studies in unanesthetized hamsters
27. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "reflow paradox."
28. Functional capillary density: An indicator of tissue perfusion?
29. A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxinemia
30. Microcirculatory models of ischemia-reperfusion injury in skin and striated muscle
31. Role of leukocytes in the initial hepatic microvascular response to endotoxin
32. Endotoxemia and neutrophil infiltration in vivo
33. Antithrombin: Structure and function
34. The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure
35. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III
36. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells
37. Effects of various doses of antithrombin on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats
38. Antithrombin inhibits in vitro lipopolysaccharide induced procoagulant activity and cytokine production
39. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin